Long Noncoding RNAs in Cancer Pathways

Cancer Cell

Volumn 29, Issue 4, 2016, Pages 452-463

  Schmitt, Adam M ^a   Chang, Howard Y ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LONG UNTRANSLATED RNA; PROTEIN; TRANSCRIPTOME; CHROMATIN; MESSENGER RNA; RNA; RNA BINDING PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

CELL MOTILITY; CHROMATIN; HUMAN; INTERACTIONS WITH RNA; MACROMOLECULE; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL AGING; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL MOTION; DISEASE COURSE; FORECASTING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METASTASIS; MOUSE; MUTATION; NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME; ULTRASTRUCTURE;

ANIMALS; BIOMARKERS, TUMOR; CELL AGING; CELL COMPARTMENTATION; CELL DIVISION; CELL MOVEMENT; CHROMATIN; DISEASE PROGRESSION; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MODELS, GENETIC; MUTATION; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING; RNA, MESSENGER; RNA, NEOPLASM; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 84962739336     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.03.010     Document Type: Review

References (168)

1. Abdelmohsen K., Panda A., Kang M.J., Xu J., Selimyan R., Yoon J.H., Martindale J.L., De S., Wood W.H., Becker K.G., Gorospe M. Senescence-associated lncRNAs: senescence-associated long noncoding RNAs. Aging Cell 2013, 12:890-900.
2. Alam T., Medvedeva Y.A., Jia H., Brown J.B., Lipovich L., Bajic V.B. Promoter analysis reveals globally differential regulation of human long non-coding RNA and protein-coding genes. PLoS One 2014, 9:e109443.
3. Anderson D.M., Anderson K.M., Chang C.L., Makarewich C.A., Nelson B.R., McAnally J.R., Kasaragod P., Shelton J.M., Liou J., Bassel-Duby R., Olson E.N. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell 2015, 160:595-606.
4. Arab K., Park Y.J., Lindroth A.M., Schafer A., Oakes C., Weichenhan D., Lukanova A., Lundin E., Risch A., Meister M., et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol. Cell 2014, 55:604-614.
5. Arun G., Diermeier S., Akerman M., Chang K.C., Wilkinson J.E., Hearn S., Kim Y., MacLeod A.R., Krainer A.R., Norton L., et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016, 30:34-51.
6. Banfai B., Jia H., Khatun J., Wood E., Risk B., Gundling W.E., Kundaje A., Gunawardena H.P., Yu Y., Xie L., et al. Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 2012, 22:1646-1657.
7. Batista P.J., Chang H.Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013, 152:1298-1307.
8. Bernard J.J., Cowing-Zitron C., Nakatsuji T., Muehleisen B., Muto J., Borkowski A.W., Martinez L., Greidinger E.L., Yu B.D., Gallo R.L. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat. Med. 2012, 18:1286-1290.
9. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
10. Bhan A., Mandal S.S. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim. Biophys. Acta 2015, 1856:151-164.
11. Bottcher R., Hoogland A.M., Dits N., Verhoef E.I., Kweldam C., Waranecki P., Bangma C.H., van Leenders G.J., Jenster G. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer. Oncotarget 2015, 6:4036-4050.
12. Brunner A.L., Beck A.H., Edris B., Sweeney R.T., Zhu S.X., Li R., Montgomery K., Varma S., Gilks T., Guo X., et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012, 13:R75.
13. Buller H.R., Bethune C., Bhanot S., Gailani D., Monia B.P., Raskob G.E., Segers A., Verhamme P., Weitz J.I. Factor XI antisense oligonucleotide for prevention of venous thrombosis. N. Engl. J. Med. 2015, 372:232-240.
14. Bussemakers M.J., van Bokhoven A., Verhaegh G.W., Smit F.P., Karthaus H.F., Schalken J.A., Debruyne F.M., Ru N., Isaacs W.B. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999, 59:5975-5979.
15. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011, 25:1915-1927.
16. Calin G.A., Liu C.G., Ferracin M., Hyslop T., Spizzo R., Sevignani C., Fabbri M., Cimmino A., Lee E.J., Wojcik S.E., et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12:215-229.
17. Chakravarty D., Sboner A., Nair S.S., Giannopoulou E., Li R., Hennig S., Mosquera J.M., Pauwels J., Park K., Kossai M., et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat. Commun. 2014, 5:5383.
18. Chu C., Qu K., Zhong F.L., Artandi S.E., Chang H.Y. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 2011, 44:667-678.
19. Chu C., Spitale R.C., Chang H.Y. Technologies to probe functions and mechanisms of long noncoding RNAs. Nat. Struct. Mol. Biol. 2015, 22:29-35.
20. Chu C., Zhang Q.C., da Rocha S.T., Flynn R.A., Bharadwaj M., Calabrese J.M., Magnuson T., Heard E., Chang H.Y. Systematic discovery of Xist RNA binding proteins. Cell 2015, 161:404-416.
21. Clemson C.M., Hutchinson J.N., Sara S.A., Ensminger A.W., Fox A.H., Chess A., Lawrence J.B. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 2009, 33:717-726.
22. Denzler R., Agarwal V., Stefano J., Bartel D.P., Stoffel M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell 2014, 54:766-776.
23. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
24. Dimitrova N., Zamudio J.R., Jong R.M., Soukup D., Resnick R., Sarma K., Ward A.J., Raj A., Lee J.T., Sharp P.A., Jacks T. LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. Mol. Cell 2014, 54:777-790.
25. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
26. Dorji T., Monti V., Fellegara G., Gabba S., Grazioli V., Repetti E., Marcialis C., Peluso S., Di Ruzza D., Neri F., Foschini M.P. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions. Hum. Pathol. 2015, 46:1275-1281.
27. Du Z., Fei T., Verhaak R.G., Su Z., Zhang Y., Brown M., Chen Y., Liu X.S. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 2013, 20:908-913.
28. Eeles R.A., Kote-Jarai Z., Giles G.G., Olama A.A., Guy M., Jugurnauth S.K., Mulholland S., Leongamornlert D.A., Edwards S.M., Morrison J., et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 2008, 40:316-321.
29. Engreitz J.M., Sirokman K., McDonel P., Shishkin A.A., Surka C., Russell P., Grossman S.R., Chow A.Y., Guttman M., Lander E.S. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell 2014, 159:188-199.
30. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., et al. The RNA component of human telomerase. Science 1995, 269:1236-1241.
31. Flockhart R.J., Webster D.E., Qu K., Mascarenhas N., Kovalski J., Kretz M., Khavari P.A. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012, 22:1006-1014.
32. Flynn R.A., Chang H.Y. Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell 2014, 14:752-761.
33. Flynn R.L., Centore R.C., O'Sullivan R.J., Rai R., Tse A., Songyang Z., Chang S., Karlseder J., Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011, 471:532-536.
34. Flynn R.L., Cox K.E., Jeitany M., Wakimoto H., Bryll A.R., Ganem N.J., Bersani F., Pineda J.R., Suva M.L., Benes C.H., et al. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science 2015, 347:273-277.
35. Gaudet D., Brisson D., Tremblay K., Alexander V.J., Singleton W., Hughes S.G., Geary R.S., Baker B.F., Graham M.J., Crooke R.M., Witztum J.L. Targeting APOC3 in the familial chylomicronemia syndrome. N. Engl. J. Med. 2014, 371:2200-2206.
36. Gendrel A.V., Heard E. Fifty years of X-inactivation research. Development 2011, 138:5049-5055.
37. Gong C., Maquat L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011, 470:284-288.
38. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
39. Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Revenko A., Arun G., Stentrup M., Gross M., et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73:1180-1189.
40. Guttman M., Rinn J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482:339-346.
41. Guttman M., Garber M., Levin J.Z., Donaghey J., Robinson J., Adiconis X., Fan L., Koziol M.J., Gnirke A., Nusbaum C., et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat. Biotechnol. 2010, 28:503-510.
42. Guttman M., Russell P., Ingolia N.T., Weissman J.S., Lander E.S. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 2013, 154:240-251.
43. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
44. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
45. Harrow J., Frankish A., Gonzalez J.M., Tapanari E., Diekhans M., Kokocinski F., Aken B.L., Barrell D., Zadissa A., Searle S., et al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res. 2012, 22:1760-1774.
46. Hezroni H., Koppstein D., Schwartz M.G., Avrutin A., Bartel D.P., Ulitsky I. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. Cell Rep. 2015, 11:1110-1122.
47. Hong D., Kurzrock R., Kim Y., Woessner R., Younes A., Nemunaitis J., Fowler N., Zhou T., Schmidt J., Jo M., et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Trans. Med. 2015, 7:314ra185.
48. Hu X., Feng Y., Zhang D., Zhao S.D., Hu Z., Greshock J., Zhang Y., Yang L., Zhong X., Wang L.P., et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 2014, 26:344-357.
49. Hu Y., Wang J., Qian J., Kong X., Tang J., Wang Y., Chen H., Hong J., Zou W., Chen Y., et al. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res. 2014, 74:6890-6902.
50. Huang W., Thomas B., Flynn R.A., Gavzy S.J., Wu L., Kim S.V., Hall J.A., Miraldi E.R., Ng C.P., Rigo F.W., et al. DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions. Nature 2015, 528:517-522.
51. Huarte M. The emerging role of lncRNAs in cancer. Nat. Med. 2015, 21:1253-1261.
52. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., Khalil A.M., Zuk O., Amit I., Rabani M., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419.
53. Hudson W.H., Pickard M.R., de Vera I.M., Kuiper E.G., Mourtada-Maarabouni M., Conn G.L., Kojetin D.J., Williams G.T., Ortlund E.A. Conserved sequence-specific lincRNA-steroid receptor interactions drive transcriptional repression and direct cell fate. Nat. Commun. 2014, 5:5395.
54. Hung T., Wang Y., Lin M.F., Koegel A.K., Kotake Y., Grant G.D., Horlings H.M., Shah N., Umbricht C., Wang P., et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 2011, 43:621-629.
55. Hung C.L., Wang L.Y., Yu Y.L., Chen H.W., Srivastava S., Petrovics G., Kung H.J. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl. Acad. Sci. USA 2014, 111:18697-18702.
56. Ideue T., Hino K., Kitao S., Yokoi T., Hirose T. Efficient oligonucleotide-mediated degradation of nuclear noncoding RNAs in mammalian cultured cells. RNA 2009, 15:1578-1587.
57. Ingolia N.T., Brar G.A., Stern-Ginossar N., Harris M.S., Talhouarne G.J., Jackson S.E., Wills M.R., Weissman J.S. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep. 2014, 8:1365-1379.
58. Iyer M.K., Niknafs Y.S., Malik R., Singhal U., Sahu A., Hosono Y., Barrette T.R., Prensner J.R., Evans J.R., Zhao S., et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015, 47:199-208.
59. Jendrzejewski J., He H., Radomska H.S., Li W., Tomsic J., Liyanarachchi S., Davuluri R.V., Nagy R., de la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl. Acad. Sci. USA 2012, 109:8646-8651.
60. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
61. Kallen A.N., Zhou X.B., Xu J., Qiao C., Ma J., Yan L., Lu L., Liu C., Yi J.S., Zhang H., et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52:101-112.
62. Karreth F.A., Tay Y., Perna D., Ala U., Tan S.M., Rust A.G., DeNicola G., Webster K.A., Weiss D., Perez-Mancera P.A., et al. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011, 147:382-395.
63. Keniry A., Oxley D., Monnier P., Kyba M., Dandolo L., Smits G., Reik W. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat. Cell Biol. 2012, 14:659-665.
64. Khaitan D., Dinger M.E., Mazar J., Crawford J., Smith M.A., Mattick J.S., Perera R.J. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011, 71:3852-3862.
65. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., van Oudenaarden A., et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 2009, 106:11667-11672.
66. Kim T.K., Hemberg M., Gray J.M., Costa A.M., Bear D.M., Wu J., Harmin D.A., Laptewicz M., Barbara-Haley K., Kuersten S., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
67. Kim T., Cui R., Jeon Y.J., Lee J.H., Lee J.H., Sim H., Park J.K., Fadda P., Tili E., Nakanishi H., et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc. Natl. Acad. Sci. USA 2014, 111:4173-4178.
68. Kim T., Cui R., Jeon Y.J., Fadda P., Alder H., Croce C.M. MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression. Oncotarget 2015, 6:18780-18789.
69. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 2010, 3:ra8.
70. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
71. Kole R., Krainer A.R., Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov. 2012, 11:125-140.
72. Kretz M., Siprashvili Z., Chu C., Webster D.E., Zehnder A., Qu K., Lee C.S., Flockhart R.J., Groff A.F., Chow J., et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013, 493:231-235.
73. Lee J.T., Bartolomei M.S. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 2013, 152:1308-1323.
74. Lee C.S., Ungewickell A., Bhaduri A., Qu K., Webster D.E., Armstrong R., Weng W.K., Aros C.J., Mah A., Chen R.O., et al. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Blood 2012, 120:3288-3297.
75. Lee S., Kopp F., Chang T.C., Sataluri A., Chen B., Sivakumar S., Yu H., Xie Y., Mendell J.T. Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell 2016, 164:69-80.
76. Lennox K.A., Behlke M.A. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 2016, 44:863-877.
77. Leveille N., Melo C.A., Rooijers K., Diaz-Lagares A., Melo S.A., Korkmaz G., Lopes R., Akbari Moqadam F., Maia A.R., Wijchers P.J., et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat. Commun. 2015, 6:6520.
78. Li L., Chang H.Y. Physiological roles of long noncoding RNAs: insight from knockout mice. Trends Cell Biol. 2014, 24:594-602.
79. Li M., Gou H., Tripathi B.K., Huang J., Jiang S., Dubois W., Waybright T., Lei M., Shi J., Zhou M., Huang J. An Apela RNA-containing negative feedback loop regulates p53-mediated apoptosis in embryonic stem cells. Cell Stem Cell 2015, 16:669-683.
80. Ling H., Fabbri M., Calin G.A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 2013, 12:847-865.
81. Ling H., Spizzo R., Atlasi Y., Nicoloso M., Shimizu M., Redis R.S., Nishida N., Gafa R., Song J., Guo Z., et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013, 23:1446-1461.
82. Ling H., Vincent K., Pichler M., Fodde R., Berindan-Neagoe I., Slack F.J., Calin G.A. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene 2015, 34:5003-5011.
83. Liu Y., Pan S., Liu L., Zhai X., Liu J., Wen J., Zhang Y., Chen J., Shen H., Hu Z. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012, 7:e35145.
84. Liu B., Sun L., Liu Q., Gong C., Yao Y., Lv X., Lin L., Yao H., Su F., Li D., et al. A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 2015, 27:370-381.
85. Lu Z., Xiao Z., Liu F., Cui M., Li W., Yang Z., Li J., Ye L., Zhang X. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 2015, 7:241-254.
86. Marin-Bejar O., Marchese F.P., Athie A., Sanchez Y., Gonzalez J., Segura V., Huang L., Moreno I., Navarro A., Monzo M., et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol. 2013, 14:R104.
87. Mattick J.S., Rinn J.L. Discovery and annotation of long noncoding RNAs. Nat. Struct. Mol. Biol. 2015, 22:5-7.
88. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., Reynolds A.P., Sandstrom R., Qu H., Brody J., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
89. McCleland M.L., Mesh K., Lorenzana E., Chopra V.S., Segal E., Watanabe C., Haley B., Mayba O., Yaylaoglu M., Gnad F., Firestein R. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J. Clin. Invest. 2016, 126:639-652.
90. McHugh C.A., Chen C.K., Chow A., Surka C.F., Tran C., McDonel P., Pandya-Jones A., Blanco M., Burghard C., Moradian A., et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 2015, 521:232-236.
91. Melo C.A., Drost J., Wijchers P.J., van de Werken H., de Wit E., Oude Vrielink J.A., Elkon R., Melo S.A., Leveille N., et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol. Cell 2013, 49:524-535.
92. Melton C., Reuter J.A., Spacek D.V., Snyder M. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat. Genet. 2015, 47:710-716.
93. Meng L., Ward A.J., Chun S., Bennett C.F., Beaudet A.L., Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 2015, 518:409-412.
94. Michalik K.M., You X., Manavski Y., Doddaballapur A., Zornig M., Braun T., John D., Ponomareva Y., Chen W., Uchida S., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 2014, 114:1389-1397.
95. Montes M., Nielsen M.M., Maglieri G., Jacobsen A., Hojfeldt J., Agrawal-Singh S., Hansen K., Helin K., van de Werken H.J., Pedersen J.S., Lund A.H. The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence. Nat. Commun. 2015, 6:6967.
96. Morris K.V., Mattick J.S. The rise of regulatory RNA. Nat. Rev. Genet. 2014, 15:423-437.
97. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
98. Nakagawa S., Ip J.Y., Shioi G., Tripathi V., Zong X., Hirose T., Prasanth K.V. Malat1 is not an essential component of nuclear speckles in mice. RNA 2012, 18:1487-1499.
99. Orom U.A., Derrien T., Beringer M., Gumireddy K., Gardini A., Bussotti G., Lai F., Zytnicki M., Notredame C., Huang Q., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
100. Pageau G.J., Hall L.L., Ganesan S., Livingston D.M., Lawrence J.B. The disappearing Barr body in breast and ovarian cancers. Nat. Rev. Cancer 2007, 7:628-633.
101. Pandey G.K., Mitra S., Subhash S., Hertwig F., Kanduri M., Mishra K., Fransson S., Ganeshram A., Mondal T., Bandaru S., et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 2014, 26:722-737.
102. Pasmant E., Sabbagh A., Vidaud M., Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011, 25:444-448.
103. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
104. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., Laxman B., Asangani I.A., Grasso C.S., Kominsky H.D., et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 2011, 29:742-749.
105. Prensner J.R., Iyer M.K., Sahu A., Asangani I.A., Cao Q., Patel L., Vergara I.A., Davicioni E., Erho N., Ghadessi M., et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat. Genet. 2013, 45:1392-1398.
106. Prensner J.R., Sahu A., Iyer M.K., Malik R., Chandler B., Asangani I.A., Poliakov A., Vergara I.A., Alshalalfa M., Jenkins R.B., et al. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 2014, 5:1434-1438.
107. Prensner J.R., Zhao S., Erho N., Schipper M., Iyer M.K., Dhanasekaran S.M., Magi-Galluzzi C., Mehra R., Sahu A., Siddiqui J., et al. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol. 2014, 15:1469-1480.
108. Puvvula P.K., Desetty R.D., Pineau P., Marchio A., Moon A., Dejean A., Bischof O. Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat. Commun. 2014, 5:5323.
109. Quagliata L., Matter M.S., Piscuoglio S., Arabi L., Ruiz C., Procino A., Kovac M., Moretti F., Makowska Z., Boldanova T., et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014, 59:911-923.
110. Quinn J.J., Chang H.Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 2015, 17:47-62.
111. Quinn J.J., Zhang Q.C., Georgiev P., Ilik I.A., Akhtar A., Chang H.Y. Rapid evolutionary turnover underlies conserved lncRNA-genome interactions. Genes Dev. 2016, 30:191-207.
112. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
113. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
114. Rippe K., Luke B. TERRA and the state of the telomere. Nat. Struct. Mol. Biol. 2015, 22:853-858.
115. Roadmap Epigenomics C., Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., Kheradpour P., Zhang Z., Wang J., et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518:317-330.
116. Sahu A., Singhal U., Chinnaiyan A.M. Long noncoding RNAs in cancer: from function to translation. Trends Cancer 2015, 1:93-109.
117. Sanchez Y., Segura V., Marin-Bejar O., Athie A., Marchese F.P., Gonzalez J., Bujanda L., Guo S., Matheu A., Huarte M. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat. Commun. 2014, 5:5812.
118. Sati S., Ghosh S., Jain V., Scaria V., Sengupta S. Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci. Nucleic Acids Res. 2012, 40:10018-10031.
119. Satpathy A.T., Chang H.Y. Long noncoding RNA in hematopoiesis and immunity. Immunity 2015, 42:792-804.
120. Sauvageau M., Goff L.A., Lodato S., Bonev B., Groff A.F., Gerhardinger C., Sanchez-Gomez D.B., Hacisuleyman E., Li E., Spence M., et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2013, 2:e01749.
121. Schmitz K.M., Mayer C., Postepska A., Grummt I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 2010, 24:2264-2269.
122. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., Young R.A., Sharp P.A. Divergent transcription from active promoters. Science 2008, 322:1849-1851.
123. Shao Y., Ye M., Jiang X., Sun W., Ding X., Liu Z., Ye G., Zhang X., Xiao B., Guo J. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer 2014, 120:3320-3328.
124. Sigova A.A., Abraham B.J., Ji X., Molinie B., Hannett N.M., Guo Y.E., Jangi M., Giallourakis C.C., Sharp P.A., Young R.A. Transcription factor trapping by RNA in gene regulatory elements. Science 2015, 350:978-981.
125. Simon M.D., Wang C.I., Kharchenko P.V., West J.A., Chapman B.A., Alekseyenko A.A., Borowsky M.L., Kuroda M.I., Kingston R.E. The genomic binding sites of a noncoding RNA. Proc. Natl. Acad. Sci. USA 2011, 108:20497-20502.
126. Simon M.D., Pinter S.F., Fang R., Sarma K., Rutenberg-Schoenberg M., Bowman S.K., Kesner B.A., Maier V.K., Kingston R.E., Lee J.T. High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature 2013, 504:465-469.
127. Spitale R.C., Flynn R.A., Zhang Q.C., Crisalli P., Lee B., Jung J.W., Kuchelmeister H.Y., Batista P.J., Torre E.A., Kool E.T., Chang H.Y. Structural imprints in vivo decode RNA regulatory mechanisms. Nature 2015, 519:486-490.
128. Takayama K., Horie-Inoue K., Katayama S., Suzuki T., Tsutsumi S., Ikeda K., Urano T., Fujimura T., Takagi K., Takahashi S., et al. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 2013, 32:1665-1680.
129. Tao R., Hu S., Wang S., Zhou X., Zhang Q., Wang C., Zhao X., Zhou W., Zhang S., Li C., et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis 2015, 36:1136-1143.
130. Tay Y., Kats L., Salmena L., Weiss D., Tan S.M., Ala U., Karreth F., Poliseno L., Provero P., Di Cunto F., et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357.
131. Tay Y., Rinn J., Pandolfi P.P. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014, 505:344-352.
132. Teschendorff A.E., Lee S.H., Jones A., Fiegl H., Kalwa M., Wagner W., Chindera K., Evans I., Dubeau L., Orjalo A., et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med. 2015, 7:108.
133. Tomlinson I., Webb E., Carvajal-Carmona L., Broderick P., Kemp Z., Spain S., Penegar S., Chandler I., Gorman M., Wood W., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 2007, 39:984-988.
134. Trapp S., Parcells M.S., Kamil J.P., Schumacher D., Tischer B.K., Kumar P.M., Nair V.K., Osterrieder N. A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J. Exp. Med. 2006, 203:1307-1317.
135. Trimarchi T., Bilal E., Ntziachristos P., Fabbri G., Dalla-Favera R., Tsirigos A., Aifantis I. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 2014, 158:593-606.
136. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
137. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
138. Tseng Y.Y., Moriarity B.S., Gong W., Akiyama R., Tiwari A., Kawakami H., Ronning P., Reuland B., Guenther K., Beadnell T.C., et al. PVT1 dependence in cancer with MYC copy-number increase. Nature 2014, 512:82-86.
139. Ulitsky I., Shkumatava A., Jan C.H., Sive H., Bartel D.P. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011, 147:1537-1550.
140. Vance K.W., Sansom S.N., Lee S., Chalei V., Kong L., Cooper S.E., Oliver P.L., Ponting C.P. The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J. 2014, 33:296-311.
141. Walsh K.M., Codd V., Smirnov I.V., Rice T., Decker P.A., Hansen H.M., Kollmeyer T., Kosel M.L., Molinaro A.M., McCoy L.S., et al. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat. Genet. 2014, 46:731-735.
142. Wan Y., Qu K., Zhang Q.C., Flynn R.A., Manor O., Ouyang Z., Zhang J., Spitale R.C., Snyder M.P., Segal E., Chang H.Y. Landscape and variation of RNA secondary structure across the human transcriptome. Nature 2014, 505:706-709.
143. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43:904-914.
144. Wang J., Liu X., Wu H., Ni P., Gu Z., Qiao Y., Chen N., Sun F., Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010, 38:5366-5383.
145. Wang K.C., Yang Y.W., Liu B., Sanyal A., Corces-Zimmerman R., Chen Y., Lajoie B.R., Protacio A., Flynn R.A., Gupta R.A., et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472:120-124.
146. Wang Y., He L., Du Y., Zhu P., Huang G., Luo J., Yan X., Ye B., Li C., Xia P., et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 2015, 16:413-425.
147. Wei J.T., Feng Z., Partin A.W., Brown E., Thompson I., Sokoll L., Chan D.W., Lotan Y., Kibel A.S., Busby J.E., et al. Can urinary PCA3 supplement PSA in the early detection of prostate cancer?. J. Clin. Oncol. 2014, 32:4066-4072.
148. West J.A., Davis C.P., Sunwoo H., Simon M.D., Sadreyev R.I., Wang P.I., Tolstorukov M.Y., Kingston R.E. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell 2014, 55:791-802.
149. Xiang J.F., Yin Q.F., Chen T., Zhang Y., Zhang X.O., Wu Z., Zhang S., Wang H.B., Ge J., Lu X., et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014, 24:513-531.
150. Xie H., Ma H., Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed. Res. Int. 2013, 2013:136106.
151. Xing Z., Lin A., Li C., Liang K., Wang S., Liu Y., Park P.K., Qin L., Wei Y., Hawke D.H., et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 2014, 159:1110-1125.
152. Yan X., Hu Z., Feng Y., Hu X., Yuan J., Zhao S.D., Zhang Y., Yang L., Shan W., He Q., et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 2015, 28:529-540.
153. Yang F., Huo X.S., Yuan S.X., Zhang L., Zhou W.P., Wang F., Sun S.H. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 2013, 49:1083-1096.
154. Yang L., Lin C., Jin C., Yang J.C., Tanasa B., Li W., Merkurjev D., Ohgi K.A., Meng D., Zhang J., et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 2013, 500:598-602.
155. Yildirim E., Kirby J.E., Brown D.E., Mercier F.E., Sadreyev R.I., Scadden D.T., Lee J.T. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 2013, 152:727-742.
156. Yoon J.H., Abdelmohsen K., Srikantan S., Yang X., Martindale J.L., De S., Huarte M., Zhan M., Becker K.G., Gorospe M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47:648-655.
157. Younger S.T., Kenzelmann-Broz D., Jung H., Attardi L.D., Rinn J.L. Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage. Nucleic Acids Res. 2015, 43:4447-4462.
158. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451:202-206.
159. Yuan S.X., Yang F., Yang Y., Tao Q.F., Zhang J., Huang G., Yang Y., Wang R.Y., Yang S., Huo X.S., et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012, 56:2231-2241.
160. Yuan J.H., Yang F., Wang F., Ma J.Z., Guo Y.J., Tao Q.F., Liu F., Pan W., Wang T.T., Zhou C.C., et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014, 25:666-681.
161. Zhang X., Gejman R., Mahta A., Zhong Y., Rice K.A., Zhou Y., Cheunsuchon P., Louis D.N., Klibanski A. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010, 70:2350-2358.
162. Zhang B., Arun G., Mao Y.S., Lazar Z., Hung G., Bhattacharjee G., Xiao X., Booth C.J., Wu J., Zhang C., Spector D.L. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012, 2:111-123.
163. Zhang E.B., Yin D.D., Sun M., Kong R., Liu X.H., You L.H., Han L., Xia R., Wang K.M., Yang J.S., et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014, 5:e1243.
164. Zhang A., Zhao J.C., Kim J., Fong K.W., Yang Y.A., Chakravarti D., Mo Y.Y., Yu J. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015, 13:209-221.
165. Zheng G.X., Do B.T., Webster D.E., Khavari P.A., Chang H.Y. Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs. Nat. Struct. Mol. Biol. 2014, 21:585-590.
166. Zhou Y., Zhong Y., Wang Y., Zhang X., Batista D.L., Gejman R., Ansell P.J., Zhao J., Weng C., Klibanski A. Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 2007, 282:24731-24742.
167. Zhou X., Yin C., Dang Y., Ye F., Zhang G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci. Rep. 2015, 5:11516.
168. Zhu Y., Rowley M.J., Bohmdorfer G., Wierzbicki A.T. A SWI/SNF chromatin-remodeling complex acts in noncoding RNA-mediated transcriptional silencing. Mol. Cell 2013, 49:298-309.